Edition:
United States

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

43.35USD
26 May 2017
Change (% chg)

$-0.15 (-0.34%)
Prev Close
$43.50
Open
$43.51
Day's High
$43.53
Day's Low
$42.86
Volume
527,992
Avg. Vol
705,963
52-wk High
$46.05
52-wk Low
$32.64

HOLX.OQ

Chart for HOLX.OQ

About

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays,... (more)

Overall

Beta: 0.95
Market Cap(Mil.): $12,138.47
Shares Outstanding(Mil.): 280.01
Dividend: --
Yield (%): --

Financials

  HOLX.OQ Industry Sector
P/E (TTM): 15.63 44.95 17.41
EPS (TTM): 2.77 -- --
ROI: 12.37 8.89 -5.42
ROE: 32.64 13.82 -4.68

BRIEF-Hologic announces Q2 revenue $715.4 million

* Hologic announces financial results for second quarter of fiscal 2017

May 10 2017

Hologic faces U.S. patent lawsuit over menstrual bleeding device

April 12 Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology developed by start-up Minerva Surgical Inc, court papers show.

Apr 12 2017

Hologic faces U.S. patent lawsuit over menstrual bleeding device

Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology developed by start-up Minerva Surgical Inc, court papers show.

Apr 12 2017

Hologic faces U.S. patent lawsuit over menstrual bleeding device

April 12 Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology developed by start-up Minerva Surgical Inc, court papers show.

Apr 12 2017

BRIEF-Hologic delivers notice that holders of 2.00pct convertible exchange senior notes due 2042 are eligible to convert

* Hologic delivers notice that holders of 2.00pct convertible exchange senior notes due 2042 are eligible to convert Source text for Eikon: Further company coverage:

Apr 03 2017

BRIEF-Cynosure says Compensation Committee established $13 mln cash pool from making severance payments related to Hologic deal

* Cynosure - Compensation committee established $13 million cash pool from making severance payments for persons without employment agreements relating to Hologic deal Source: (http://bit.ly/2lL68PF) Further company coverage:

Feb 22 2017

BRIEF-FDA grants PMA approval for Hologic's Aptima hepatitis C Quant DX Assay

* FDA grants PMA approval for Hologic's Aptima hepatitis C Quant DX Assay Source text for Eikon: Further company coverage:

Feb 15 2017

BRIEF-Cynosure agrees to termination fee of $57.7 mln for Hologic deal

* Hologic - upon termination of deal under specified circumstances Cynosure has agreed to pay co termination fee of about $57.7 million Source text - http://bit.ly/2kuOElN Further company coverage:

Feb 14 2017

Hologic to buy Cynosure to expand into medical aesthetics

Hologic Inc said on Tuesday it would acquire medical aesthetics company Cynosure Inc for $1.65 billion as it looks to capitalize on an increase in medical procedures that are not traditionally reimbursed.

Feb 14 2017

UPDATE 3-Hologic to buy Cynosure to expand into medical aesthetics

* Cynosure shares up 28 pct; Hologic down 3.6 pct (Adds analyst comments, details)

Feb 14 2017

More From Around the Web

Earnings vs. Estimates